SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack in the Box is trending due to a high-conviction short squeeze thesis, with retail investors highlighting its small float and significant short interest relative to its available shares. Community members are actively debating the stock's potential for a massive move, frequently comparing its technical setup to other major short squeeze plays and weighing it against competitors in the fast-food sector.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is experiencing significant volatility and trading momentum as investors weigh a major divergence between analyst delivery forecasts and bullish sentiment from prediction markets ahead of a key production report. While the community remains deeply divided, with vocal bears focusing on valuation concerns and recent short positions, many bulls are aggressively betting on a delivery beat and long-term breakthroughs in AI, robotics, and energy infrastructure.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as investors focus on the upcoming Vitreoretinal Benefit Society presentation and the potential for a swift NDA filing following strong Phase 3 superiority data for its wet AMD candidate. While the community is actively debating the company's regulatory path and the competitive landscape against standard anti-VEGF treatments, sentiments remain divided between those anticipating a buyout or breakthrough and those concerned by ongoing stock volatility.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is rallying following reports that the company plans to launch a cloud-computing division to monetize excess AI infrastructure, shifting investor perception from seeing its heavy capital expenditure as a pure cost toward a potential revenue-generating asset. Community sentiment is deeply divided, with bulls viewing this as a strategic ROI catalyst that justifies recent infrastructure investments, while bears remain skeptical, dismissing the move as a desperate mitigation strategy for overbuilt capacity and failed prior initiatives.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is facing heightened volatility and intense community debate as participants weigh the impact of broader crypto market headwinds against potential speculative catalysts. While some investors are aggressively accumulating during price dips, others remain deeply skeptical, citing ongoing consolidation and lingering concerns over long-term utility.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is facing significant community frustration as shareholders express impatience over the lack of major catalysts despite recent executive share accumulation. Investors are actively debating the stock's sluggish movement compared to the broader biotech sector, with ongoing speculation regarding management silence and potential M&A activity driving current sentiment.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is attracting significant attention as users highlight its role in the growing agentic AI economy on the Base chain, citing strong protocol revenue and infrastructure-focused utility as key growth drivers. Community members are actively debating the token's long-term potential, with many discussing aggressive accumulation strategies and expectations for a major repricing as the project continues to ship new features.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened community interest driven by speculation of a potential short squeeze, as retail investors closely watch its elevated short interest and technical chart patterns. Discussions are currently split between bullish sentiment regarding the company's expansion into enterprise AI markets like telecommunications and energy, and frustration over the stock's recent performance despite underlying partnership developments.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is experiencing significant investor focus driven by its pivot toward enterprise-grade Agentic AI orchestration and a potential short squeeze scenario, fueled by high short interest and massive institutional accumulation on heavy volume. Community sentiment is deeply polarized between long-term investors highlighting strong fundamentalssuch as GAAP profitability, a substantial cash position, and a strategic role in AI workflow governanceand frustrated traders pointing to prolonged price stagnation and intense algorithmic manipulation.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines ($UMAC) is surging as investor interest spikes around potential U.S. government investment and funding in the domestic drone sector, with community discussion highlighting the company's manufacturing growth and strategic partnerships. Traders are actively debating the sustainability of this momentum, weighing reports of insider activity and potential future share offerings against the broader defense-tech narrative driving the basket.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mobia Medical, Inc. operates as a commercial-stage medical device company. It engages in developing solutions for stroke recovery survivors with motor impairments. The company was founded by Lawrence James Cauller, Navzer Engineer, Thomas Jordan Curnes II, and William Michael Rosellini on March 5, 2007 and is headquartered in Austin, TX.

Mobia Medical Inc.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$13.16
Prev Close	$13.40
Open	$13.50
Dividend Yield	N/A
50-Day Moving Average	$13.01
Beta	0.00
Avg. Volume	242,679.03
PE Ratio	N/A

52-Week High	$15.29
52-Week Low	$10.19
Market Capitalization	$445.54M
EPS (Annual)	-$1.41
Price to Book	-2.61
Revenue Per Employee	$191,862.14

Feed

News

Sentiment

Fundamentals

Info

MOBISky-mobi Limited

Latest MOBI News